Product Code: ETC338486 | Publication Date: Aug 2022 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
Malaysia Pharmaceuticals market currently, in 2023, has witnessed an HHI of 787, Which has decreased slightly as compared to the HHI of 839 in 2017. The market is moving towards highly competitive. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
The pharmaceuticals market in Malaysia is poised for steady growth due to factors such as an aging population, increasing healthcare expenditure, and a growing prevalence of chronic diseases. The government`s initiatives to enhance healthcare infrastructure and promote research and development activities further contribute to the positive outlook. Additionally, a surge in demand for generic medicines and a growing emphasis on biotechnology and specialty pharmaceuticals are anticipated to shape the future of the pharmaceutical industry in Malaysia.
The pharmaceuticals market in Malaysia is poised for significant growth. Factors such as an aging population, increasing healthcare expenditure, and a rising prevalence of chronic diseases are driving this expansion. The government`s initiatives to enhance the healthcare system and promote research and development activities in the pharmaceutical sector are also key contributors. Furthermore, the ongoing trend of generic drug manufacturing and a growing emphasis on biopharmaceuticals will likely shape the market`s future.
The pharmaceuticals market in Malaysia is expected to expand due to an aging population and increased healthcare spending. Challenges include regulatory compliance and the need for innovation in drug development.
The pharmaceuticals market in Malaysia experienced significant changes during the COVID-19 pandemic. There was increased demand for essential medicines and healthcare products, while disruptions in the supply chain affected the availability of certain drugs. The pandemic also accelerated the adoption of telemedicine and digital health solutions. These trends are expected to continue, with the pharmaceutical market focusing on innovation, digitalization, and ensuring a robust supply chain for critical healthcare products.
The pharmaceuticals market in Malaysia has been experiencing robust growth, with key players such as Pfizer Malaysia, GlaxoSmithKline Malaysia, and Novartis Malaysia dominating the landscape. These pharmaceutical giants have been investing heavily in research and development to introduce innovative medications and healthcare solutions to address various medical conditions and contribute to the overall well-being of the population.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Pharmaceuticals Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Pharmaceuticals Market - Industry Life Cycle |
3.4 Malaysia Pharmaceuticals Market - Porter's Five Forces |
3.5 Malaysia Pharmaceuticals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Malaysia Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.7 Malaysia Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Malaysia Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2021 & 2031F |
3.9 Malaysia Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
4 Malaysia Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Pharmaceuticals Market Trends |
6 Malaysia Pharmaceuticals Market, By Types |
6.1 Malaysia Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Pharmaceuticals Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Malaysia Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2021-2031F |
6.1.4 Malaysia Pharmaceuticals Market Revenues & Volume, By Biologics, 2021-2031F |
6.2 Malaysia Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.2.3 Malaysia Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2021-2031F |
6.2.4 Malaysia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.3 Malaysia Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Pharmaceuticals Market Revenues & Volume, By Oral, 2021-2031F |
6.3.3 Malaysia Pharmaceuticals Market Revenues & Volume, By Parenteral, 2021-2031F |
6.3.4 Malaysia Pharmaceuticals Market Revenues & Volume, By Others, 2021-2031F |
6.4 Malaysia Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Malaysia Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2021-2031F |
6.4.3 Malaysia Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2021-2031F |
6.5 Malaysia Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Malaysia Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2021-2031F |
6.5.3 Malaysia Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2021-2031F |
7 Malaysia Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Malaysia Pharmaceuticals Market Export to Major Countries |
7.2 Malaysia Pharmaceuticals Market Imports from Major Countries |
8 Malaysia Pharmaceuticals Market Key Performance Indicators |
9 Malaysia Pharmaceuticals Market - Opportunity Assessment |
9.1 Malaysia Pharmaceuticals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Malaysia Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.3 Malaysia Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Malaysia Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2021 & 2031F |
9.5 Malaysia Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
10 Malaysia Pharmaceuticals Market - Competitive Landscape |
10.1 Malaysia Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |